Your browser doesn't support javascript.
loading
Integrating biomarkers across omic platforms: an approach to improve stratification of patients with indolent and aggressive prostate cancer.
Murphy, Keefe; Murphy, Brendan T; Boyce, Susie; Flynn, Louise; Gilgunn, Sarah; O'Rourke, Colm J; Rooney, Cathy; Stöckmann, Henning; Walsh, Anna L; Finn, Stephen; O'Kennedy, Richard J; O'Leary, John; Pennington, Stephen R; Perry, Antoinette S; Rudd, Pauline M; Saldova, Radka; Sheils, Orla; Shields, Denis C; Watson, R William.
Afiliación
  • Murphy K; UCD School of Mathematics and Statistics, University College Dublin, Ireland.
  • Murphy BT; UCD School of Mathematics and Statistics, University College Dublin, Ireland.
  • Boyce S; UCD School of Mathematics and Statistics, University College Dublin, Ireland.
  • Flynn L; UCD School of Medicine, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Ireland.
  • Gilgunn S; Department of Histopathology, Central Pathology Laboratory, Trinity College, St James Hospital, University of Dublin, Ireland.
  • O'Rourke CJ; School of Biotechnology, Dublin City University, Ireland.
  • Rooney C; Biomedical Diagnostics Institute, National Centre for Sensor Research, Dublin City University, Ireland.
  • Stöckmann H; Prostate Molecular Oncology, Institute of Molecular Medicine, Trinity College Dublin, St James Hospital, Dublin, Ireland.
  • Walsh AL; UCD School of Medicine, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Ireland.
  • Finn S; NIBRT GlycoScience Group, National Institute for Bioprocessing Research and Training, Dublin, Ireland.
  • O'Kennedy RJ; Prostate Molecular Oncology, Institute of Molecular Medicine, Trinity College Dublin, St James Hospital, Dublin, Ireland.
  • O'Leary J; Department of Histopathology, Central Pathology Laboratory, Trinity College, St James Hospital, University of Dublin, Ireland.
  • Pennington SR; School of Biotechnology, Dublin City University, Ireland.
  • Perry AS; Biomedical Diagnostics Institute, National Centre for Sensor Research, Dublin City University, Ireland.
  • Rudd PM; Department of Histopathology, Central Pathology Laboratory, Trinity College, St James Hospital, University of Dublin, Ireland.
  • Saldova R; UCD School of Medicine, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Ireland.
  • Sheils O; Prostate Molecular Oncology, Institute of Molecular Medicine, Trinity College Dublin, St James Hospital, Dublin, Ireland.
  • Shields DC; Cancer Biology and Therapeutics Lab, UCD School of Biomolecular and Biomedical Science, University College Dublin, Ireland.
  • Watson RW; NIBRT GlycoScience Group, National Institute for Bioprocessing Research and Training, Dublin, Ireland.
Mol Oncol ; 12(9): 1513-1525, 2018 09.
Article en En | MEDLINE | ID: mdl-29927052

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Biomarcadores de Tumor / Proteómica Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: Mol Oncol Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Irlanda Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Biomarcadores de Tumor / Proteómica Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: Mol Oncol Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Irlanda Pais de publicación: Estados Unidos